The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
GiGi’s Playhouse Summer Program
This summer, i4c has sponsored GiGi’s Playhouse NYC to help them to create a summer program FREE to a total of more than 50 adults, teens and children with Down’s…
see project